Back to Search
Start Over
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19
- Source :
- Cardiol J
- Publication Year :
- 2020
-
Abstract
- BACKGROUND: Cardiovascular risk factors and usage of cardiovascular medication are prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the cardiovascular implications of COVID-19. The goal herein, was to evaluate the prognostic impact of having heart disease (HD) and taking cardiovascular medications in a population diagnosed of COVID-19 who required hospitalization. Also, we studied the development of cardiovascular events during hospitalization. METHODS: Consecutive patients with definitive diagnosis of COVID-19 made by a positive real time- -polymerase chain reaction of nasopharyngeal swabs who were admitted to the hospital from March 15 to April 14 were included in a retrospective registry. The association of HD with mortality and with mortality or respiratory failure were the primary and secondary objectives, respectively. RESULTS: A total of 859 patients were included in the present analysis. Cardiovascular risk factors were related to death, particularly diabetes mellitus (hazard ratio in the multivariate analysis: 1.810 [1.159- -2.827], p = 0.009). A total of 113 (13.1%) patients had HD. The presence of HD identified a group of patients with higher mortality (35.4% vs. 18.2%, p < 0.001) but HD was not independently related to prognosis; renin-angiotensin-aldosterone system inhibitors, calcium channel blockers, diuretics and beta-blockers did not worsen prognosis. Statins were independently associated with decreased mortality (0.551 [0.329-0.921], p = 0.023). Cardiovascular events during hospitalization identified a group of patients with poor outcome (mortality 31.8% vs. 19.3% without cardiovascular events, p = 0.007). CONCLUSIONS: The presence of HD is related to higher mortality. Cardiovascular medications taken before admission are not harmful, statins being protective. The development of cardiovascular events during the course of the disease is related to poor outcome.
- Subjects :
- Male
medicine.medical_specialty
Heart disease
Heart Diseases
Population
Comorbidity
Internal medicine
Diabetes mellitus
medicine
Humans
education
Pandemics
Aged
Retrospective Studies
education.field_of_study
business.industry
SARS-CoV-2
Hazard ratio
COVID-19
Retrospective cohort study
Cardiovascular Agents
General Medicine
medicine.disease
Prognosis
Heart failure
Cardiovascular agent
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 1898018X
- Volume :
- 28
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Cardiology journal
- Accession number :
- edsair.doi.dedup.....ea0df2db2d9211139d843bd958e4b8cd